2m 2m 2m 2m 2m 2m 2m
CONTINEUM THE-A (CTNM)
NASDAQ
$14.62$0.00 (0.00%)
Price as of Jul 14, 2026 6:18 AM EDT- $478.4MMarket Cap
- 291.96%1-Year Change
- BiotechnologyIndustry
CONTINEUM THE-A (CTNM)
$14.62$0.00 (0.00%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
SUVRETTA CAPITAL MANAGEMENT, LLC | 7.60% | 2.8M | 0 (0.00%) | Mar 31, 2026 |
JANUS HENDERSON GROUP PLC | 7.32% | 2.7M | +285,857 (+10.45%) | Mar 31, 2026 |
JOHNSON & JOHNSON | 5.29% | 2.0M | 0 (0.00%) | Mar 31, 2026 |
FRANKLIN RESOURCES INC | 4.92% | 1.8M | -40,140 (-2.18%) | Mar 31, 2026 |
BALYASNY ASSET MANAGEMENT L.P. | 4.51% | 1.7M | -157,165 (-9.32%) | Mar 31, 2026 |
MILLENNIUM MANAGEMENT LLC | 4.11% | 1.5M | +704,762 (+45.90%) | Mar 31, 2026 |
BAKER BROS. ADVISORS LP | 3.80% | 1.4M | 0 (0.00%) | Mar 31, 2026 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
VANGUARD INDEX FUNDS | 3.17% | 1.2M | +68,657 (+5.80%) | Mar 31, 2026 |
FRANKLIN STRATEGIC SERIES | 1.81% | 676,121 | 0 (0.00%) | Apr 30, 2026 |
FIDELITY SELECT PORTFOLIOS | 1.20% | 450,000 | 0 (0.00%) | Apr 30, 2026 |
FIDELITY ADVISOR SERIES VII | 0.75% | 280,000 | 0 (0.00%) | Apr 30, 2026 |
iSHARES TRUST | 0.70% | 262,032 | 0 (0.00%) | Apr 30, 2026 |
SCHWAB STRATEGIC TRUST | 0.27% | 102,803 | +9,178 (+8.93%) | Feb 28, 2026 |
VARIABLE INSURANCE PRODUCTS FUND IV | 0.21% | 80,000 | 0 (0.00%) | Mar 31, 2026 |
Current Ownership Distribution
- Institutions121.2M (85.50%)
- Mutual Funds17.7M (12.50%)
- Insiders2.8M (2.00%)
- Other0 (0.00%)
Insider Transactions
- 2.00% (2.8M)Current InsiderOwnership (%, shares)
- 0Number of InsiderBuying (last 12 months)
- $0.00Amount of InsiderBuying (last 12 months)
- 3Number of InsiderSelling (last 12 months)
- $28.1MAmount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
Lorrain Daniel S. Chief Scientific Officer | Exempt | Jul 09, 2026 | $0.00 | 25 | $0.00 | 33,257 |
Lorrain Daniel S. Chief Scientific Officer | Exempt | Jul 09, 2026 | $25.25 | 25 | $1.01 | 135,227 |
Lorrain Daniel S. Chief Scientific Officer | Sell | Jul 09, 2026 | $400.00 | 25 | $16.00 | 135,202 |
Stengone Carmine N. CEO and President | Exempt | Jul 08, 2026 | $0.00 | 2,500 | $0.00 | 279,430 |
Lorrain Daniel S. Chief Scientific Officer | Exempt | Jul 08, 2026 | $1,025.15 | 1,015 | $1.01 | 136,217 |
Stengone Carmine N. CEO and President | Exempt | Jul 08, 2026 | $2,525.00 | 2,500 | $1.01 | 19,717 |
Lorrain Daniel S. Chief Scientific Officer | Sell | Jul 08, 2026 | $16,240.00 | 1,015 | $16.00 | 135,202 |
Stengone Carmine N. CEO and President | Sell | Jul 08, 2026 | $40,000.00 | 2,500 | $16.00 | 17,217 |
Lorrain Daniel S. Chief Scientific Officer | Exempt | Jul 08, 2026 | $0.00 | 1,015 | $0.00 | 33,282 |
Lorrain Daniel S. Chief Scientific Officer | Exempt | Jul 01, 2026 | $0.00 | 4,183 | $0.00 | 34,297 |
Lorrain Daniel S. Chief Scientific Officer | Exempt | Jul 01, 2026 | $4,224.83 | 4,183 | $1.01 | 143,555 |
Lorrain Daniel S. Chief Scientific Officer | Sell | Jul 01, 2026 | $91,681.53 | 5,852 | $15.67 | 137,703 |
Lorrain Daniel S. Chief Scientific Officer | Sell | Jul 01, 2026 | $40,608.49 | 2,501 | $16.24 | 135,202 |
Lorrain Daniel S. Chief Scientific Officer | Exempt | Jun 30, 2026 | $0.00 | 28,826 | $0.00 | 38,480 |
Lorrain Daniel S. Chief Scientific Officer | Exempt | Jun 30, 2026 | $29,114.26 | 28,826 | $1.01 | 168,198 |
Lorrain Daniel S. Chief Scientific Officer | Sell | Jun 30, 2026 | $462,288.33 | 28,826 | $16.04 | 139,372 |
Ware Olivia C | Award | Jun 26, 2026 | $0.00 | 19,000 | $0.00 | 19,000 |
Lorrain Daniel S. Chief Scientific Officer | Sell | Mar 02, 2026 | $62,585.03 | 4,170 | $15.01 | 151,882 |
Lorrain Daniel S. Chief Scientific Officer | Exempt | Feb 19, 2026 | $0.00 | 100 | $0.00 | 75,430 |
Lorrain Daniel S. Chief Scientific Officer | Exempt | Feb 19, 2026 | $101.00 | 100 | $1.01 | 156,152 |
Lorrain Daniel S. Chief Scientific Officer | Sell | Feb 19, 2026 | $1,600.00 | 100 | $16.00 | 156,052 |
Stengone Carmine N. CEO and President | Exempt | Feb 11, 2026 | $0.00 | 400 | $0.00 | 128,017 |
Lorrain Daniel S. Chief Scientific Officer | Exempt | Feb 11, 2026 | $0.00 | 400 | $0.00 | 75,530 |
Stengone Carmine N. CEO and President | Exempt | Feb 11, 2026 | $504.00 | 400 | $1.26 | 15,354 |
Lorrain Daniel S. Chief Scientific Officer | Exempt | Feb 11, 2026 | $404.00 | 400 | $1.01 | 156,452 |
Stengone Carmine N. CEO and President | Sell | Feb 11, 2026 | $6,400.00 | 400 | $16.00 | 14,954 |
Lorrain Daniel S. Chief Scientific Officer | Sell | Feb 11, 2026 | $6,400.00 | 400 | $16.00 | 156,052 |
Lorrain Daniel S. Chief Scientific Officer | Sell | Feb 03, 2026 | $44,468.70 | 3,000 | $14.82 | 157,222 |
Lorrain Daniel S. Chief Scientific Officer | Sell | Feb 03, 2026 | $17,836.77 | 1,170 | $15.25 | 156,052 |
Watkins Tim CMO & Head of Development | Award | Jan 30, 2026 | $0.00 | 160,000 | $0.00 | 160,000 |